Should we focus on sustainable thromboprophylaxis and avoid overuse of low-molecular-weight heparins?
Low-molecular-weight heparins (LMWHs) have become a near-routine prescription for venous thromboembolism (VTE) prevention in hospitalized patients in several parts of the world. Their use may be reinforced by embedded order sets and ‘opt-out’ defaults. However, the absolute clinical benefit of unive...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2026-05-01
|
| Serie: | Research and Practice in Thrombosis and Haemostasis |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2475037926034527 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|